| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Francesco Benedetti, Sara Dallaspezia, Mara Cigala Fulgosi, Barbara Barbini, Cristina Colombo, Enrico Smerald. Phase advance is an actimetric correlate of antidepressant response to sleep deprivation and light therapy in bipolar depression. Chronobiology international. vol 24. issue 5. 2007-12-06. PMID:17994346. |
the combination of total sleep deprivation (tsd) and light therapy (lt) in bipolar depression causes rapid antidepressant effects, and its mechanism of action has been hypothesized to involve the enhancement of all of the monoaminergic systems targeted by antidepressant drugs (serotonin, dopamine, norepinephrine). |
2007-12-06 |
2023-08-12 |
Not clear |
| Laura Mercolini, Roberto Mandrioli, Roberto Cazzolla, Mario Amore, Maria Augusta Ragg. HPLC analysis of the novel antidepressant duloxetine in human plasma after an original solid-phase extraction procedure. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences. vol 856. issue 1-2. 2007-11-30. PMID:17572161. |
duloxetine is the most recent serotonin and norepinephrine reuptake inhibitor (snri) drug introduced for the therapy of depression. |
2007-11-30 |
2023-08-12 |
human |
| Andreas Broocks, Uwe Ahrendt, Marcel Somme. [Physical training in the treatment of depressive disorders]. Psychiatrische Praxis. vol 34 Suppl 3. 2007-11-30. PMID:17786888. |
for instance, there is experimental evidence, that regular exercise induces a downregulation of central 5-ht(2c) receptors which play an important role in the pathogenesis of anxiety and depression. |
2007-11-30 |
2023-08-12 |
Not clear |
| Alec Roy, Xian-Zhang Hu, Malvin N Janal, David Goldma. Interaction between childhood trauma and serotonin transporter gene variation in suicide. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 32. issue 9. 2007-11-29. PMID:17356577. |
although the serotonin transporter promoter polymorphism (5-httlpr) contributes to depression and suicidality in a fashion modulated by environmental stress, 5-httlpr has been little examined in relation to suicidal behavior in substance dependence. |
2007-11-29 |
2023-08-12 |
Not clear |
| Alfonso González, Fili Fazzino, Mirta Castillo, Salvador Mata, Lucimey Lim. Serotonin, 5-HT1A serotonin receptors and proliferation of lymphocytes in major depression patients. Neuroimmunomodulation. vol 14. issue 1. 2007-11-28. PMID:17700035. |
serotonin, 5-ht1a serotonin receptors and proliferation of lymphocytes in major depression patients. |
2007-11-28 |
2023-08-12 |
human |
| Alfonso González, Fili Fazzino, Mirta Castillo, Salvador Mata, Lucimey Lim. Serotonin, 5-HT1A serotonin receptors and proliferation of lymphocytes in major depression patients. Neuroimmunomodulation. vol 14. issue 1. 2007-11-28. PMID:17700035. |
basal proliferation was three times higher in depressed patients than in controls, whereas no response to mitogen was obtained, and 5-ht(1a) receptors significantly reacted to the agonist, with increases of about 31-54% at 10, 20 and 40 nm of the specific agonist, indicating initial activation probably in relation to autoimmunity and overreactivity of these receptors in depression. |
2007-11-28 |
2023-08-12 |
human |
| Alfonso González, Fili Fazzino, Mirta Castillo, Salvador Mata, Lucimey Lim. Serotonin, 5-HT1A serotonin receptors and proliferation of lymphocytes in major depression patients. Neuroimmunomodulation. vol 14. issue 1. 2007-11-28. PMID:17700035. |
the antagonist reduced proliferation in mitogen-stimulated lymphocytes, 50% in controls and 70% in depressed patients, with a differential concentration dependency; probably, these receptors are more sensitive in depression due to increased 5-ht(1a) receptor transduction. |
2007-11-28 |
2023-08-12 |
human |
| Ingela Hammar, Katinka Stecina, Elzbieta Jankowsk. Differential modulation by monoamine membrane receptor agonists of reticulospinal input to lamina VIII feline spinal commissural interneurons. The European journal of neuroscience. vol 26. issue 5. 2007-11-28. PMID:17767499. |
application of alpha(1) and 5-ht(2) agonists resulted in a facilitation of responses in all investigated neurons while application of alpha(2), 5-ht(1a/7) and 5-ht(3) agonists resulted in a depression. |
2007-11-28 |
2023-08-12 |
Not clear |
| U Dannlowski, P Ohrmann, J Bauer, H Kugel, B T Baune, C Hohoff, A Kersting, V Arolt, W Heindel, J Deckert, T Suslo. Serotonergic genes modulate amygdala activity in major depression. Genes, brain, and behavior. vol 6. issue 7. 2007-11-20. PMID:17284168. |
this study used an imaging genomics approach to investigate amygdala activity in major depression as a function of common functional polymorphisms in the serotonin transporter gene (5-httlpr) and the serotonin receptor 1a gene (5-ht(1a)-1019c/g). |
2007-11-20 |
2023-08-12 |
Not clear |
| Henrik B Rasmussen, Thomas M Werg. Novel procedure for genotyping of the human serotonin transporter gene-linked polymorphic region (5-HTTLPR)--a region with a high level of allele diversity. Psychiatric genetics. vol 17. issue 5. 2007-11-20. PMID:17728667. |
a variable number of tandem repeats in the promoter region of the serotonin transporter gene, designated 5-httlpr, affects the transcription of this gene and appears to modulate the susceptibility to a variety of diseases including depression. |
2007-11-20 |
2023-08-12 |
human |
| George I Papakosta. Limitations of contemporary antidepressants: tolerability. The Journal of clinical psychiatry. vol 68 Suppl 10. 2007-11-19. PMID:17900204. |
in this article, the rates of common adverse events among the newer (posttricyclic era) antidepressants are compared with those among the selective serotonin reuptake inhibitors, the most popular, contemporary first-line treatments for depression. |
2007-11-19 |
2023-08-12 |
Not clear |
| Izchak Kohen, Marc L Gordon, Peter Man. Serotonin syndrome in elderly patients treated for psychotic depression with atypical antipsychotics and antidepressants: two case reports. CNS spectrums. vol 12. issue 8. 2007-11-13. PMID:17667887. |
serotonin syndrome in elderly patients treated for psychotic depression with atypical antipsychotics and antidepressants: two case reports. |
2007-11-13 |
2023-08-12 |
Not clear |
| Izchak Kohen, Marc L Gordon, Peter Man. Serotonin syndrome in elderly patients treated for psychotic depression with atypical antipsychotics and antidepressants: two case reports. CNS spectrums. vol 12. issue 8. 2007-11-13. PMID:17667887. |
we report two cases of serotonin syndrome in elderly patients during treatment of psychotic depression with atypical antipsychotics and antidepressants. |
2007-11-13 |
2023-08-12 |
Not clear |
| Izchak Kohen, Marc L Gordon, Peter Man. Serotonin syndrome in elderly patients treated for psychotic depression with atypical antipsychotics and antidepressants: two case reports. CNS spectrums. vol 12. issue 8. 2007-11-13. PMID:17667887. |
clinicians treating elderly patients with a combination of serotonergic antidepressants and atypical antipsychotics for psychotic depression should be aware of the potential for serotonin syndrome. |
2007-11-13 |
2023-08-12 |
Not clear |
| B Eliot Col. Diabetic peripheral neuropathic pain: recognition and management. Pain medicine (Malden, Mass.). vol 8 Suppl 2. 2007-11-05. PMID:17714113. |
one of these medications, duloxetine has been established to significantly improve pain and to address depression by its reuptake inhibition of norepinephrine and serotonin. |
2007-11-05 |
2023-08-12 |
Not clear |
| Diogo Telles-Correia, Diogo F Guerreiro, Sónia Oliveira, M Luísa Figueir. [Differences between SSRI's pharmacokinetics and pharmacodinamics]. Acta medica portuguesa. vol 20. issue 2. 2007-11-02. PMID:17868523. |
selective serotonin reuptake inhibitors (ssri) are nowadays the preferred treatment for patients with depression and anxiety disorders, when compared with traditional tricyclic antidepressants. |
2007-11-02 |
2023-08-12 |
Not clear |
| Sanjay Gupta, Nikhil Nihalani, Prakash Masan. Duloxetine: review of its pharmacology, and therapeutic use in depression and other psychiatric disorders. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists. vol 19. issue 2. 2007-10-31. PMID:17612852. |
the coming of the selective serotonin (5-ht) reuptake inhibitors (ssris) marked a new era in the treatment of depression. |
2007-10-31 |
2023-08-12 |
Not clear |
| Atsuko Ikenouchi-Sugita, Reiji Yoshimura, Jun Nakamur. [Review of pharmacological efficacies and side effects of antidepressants]. Nihon rinsho. Japanese journal of clinical medicine. vol 65. issue 9. 2007-10-31. PMID:17876986. |
selective serotonin reuptake inhibitors (ssris) and serotonin noradrenaline reuptake inhibitors (snris) are most popularly prescribed for anxiety disorders as well as mild or moderate depression. |
2007-10-31 |
2023-08-12 |
Not clear |
| Yoshiaki Maruyama, Mitsuhiko Yamad. [TREK-1: a potential target for novel antidepressants]. Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology. vol 27. issue 4. 2007-10-30. PMID:17879592. |
the neurotransmitter serotonin (5-ht: 5-hydroxytryptamin) was suggested to be involved in the pathogenesis of depression as well as in the mechanisms of antidepressant treatments. |
2007-10-30 |
2023-08-12 |
mouse |
| G C Lasiuk, K M Hegadore. The effects of estradiol on central serotonergic systems and its relationship to mood in women. Biological research for nursing. vol 9. issue 2. 2007-10-30. PMID:17909167. |
to shed light on the complex interactions among estrogens, serotonin, and mood, we briefly examine (a) central serotonin systems and their relationship to mood and mood disorders, (b) nonreproductive effects of estrogens on those systems, (c) potential points of intersection between serotonin systems and estrogens, and (d) research into the use of exogenous estrogen in depression in women. |
2007-10-30 |
2023-08-12 |
Not clear |